The post 6 Altcoins to Watch as Politics Drives Crypto appeared on BitcoinEthereumNews.com. Ethereum and Solana are seen as the top “blue chip” altcoins with strong links to the Trump family Chainlink, XRP, and ADA are gaining relevance through direct engagement with US policymakers Political narratives are creating a unique catalyst for these six altcoins in a weak market While the broader crypto market pulls back, a handful of altcoins with direct links to Donald Trump and the White House are getting a second look from traders. According to Altcoin Buzz, these six tokens have a unique political narrative that could set them apart, regardless of short-term market weakness. The Blue Chips: Ethereum and Solana Lead Even at the top of the market, the Trump connection is strong. Why is Ethereum considered a “Trump Coin”? Ethereum remains the strongest White House-linked asset, largely due to frequent promotion by Trump’s family, particularly Eric Trump. This has fueled speculation that ETH is a core long-term holding for the family, making it a key beneficiary of any pro-crypto government policy.  At press time, Ethereum trades at $4,404, down 0.86% on the day and over 6% in the past week. Despite short-term weakness, the consistent visibility of ETH in Trump’s orbit makes it a leading beneficiary of potential government-driven crypto adoption. What’s Solana’s connection? Alongside Ethereum, Solana has also captured attention. Trump previously used the Solana network to launch political memecoins, and the launch of the Trump-backed USD1 stablecoin on Solana.  Solana trades at $199, reflecting a weekly decline of just 2.49%, signaling relative strength compared to peers. Chainlink, XRP, and Cardano in Policy Conversations Chainlink has emerged as a government partner by integrating official U.S. economic data feeds, a move that underscores its practical utility. Despite this milestone, LINK trades at $22.93, losing more than 11% over the past week.  Nevertheless, its central role in blockchain… The post 6 Altcoins to Watch as Politics Drives Crypto appeared on BitcoinEthereumNews.com. Ethereum and Solana are seen as the top “blue chip” altcoins with strong links to the Trump family Chainlink, XRP, and ADA are gaining relevance through direct engagement with US policymakers Political narratives are creating a unique catalyst for these six altcoins in a weak market While the broader crypto market pulls back, a handful of altcoins with direct links to Donald Trump and the White House are getting a second look from traders. According to Altcoin Buzz, these six tokens have a unique political narrative that could set them apart, regardless of short-term market weakness. The Blue Chips: Ethereum and Solana Lead Even at the top of the market, the Trump connection is strong. Why is Ethereum considered a “Trump Coin”? Ethereum remains the strongest White House-linked asset, largely due to frequent promotion by Trump’s family, particularly Eric Trump. This has fueled speculation that ETH is a core long-term holding for the family, making it a key beneficiary of any pro-crypto government policy.  At press time, Ethereum trades at $4,404, down 0.86% on the day and over 6% in the past week. Despite short-term weakness, the consistent visibility of ETH in Trump’s orbit makes it a leading beneficiary of potential government-driven crypto adoption. What’s Solana’s connection? Alongside Ethereum, Solana has also captured attention. Trump previously used the Solana network to launch political memecoins, and the launch of the Trump-backed USD1 stablecoin on Solana.  Solana trades at $199, reflecting a weekly decline of just 2.49%, signaling relative strength compared to peers. Chainlink, XRP, and Cardano in Policy Conversations Chainlink has emerged as a government partner by integrating official U.S. economic data feeds, a move that underscores its practical utility. Despite this milestone, LINK trades at $22.93, losing more than 11% over the past week.  Nevertheless, its central role in blockchain…

6 Altcoins to Watch as Politics Drives Crypto

  • Ethereum and Solana are seen as the top “blue chip” altcoins with strong links to the Trump family
  • Chainlink, XRP, and ADA are gaining relevance through direct engagement with US policymakers
  • Political narratives are creating a unique catalyst for these six altcoins in a weak market

While the broader crypto market pulls back, a handful of altcoins with direct links to Donald Trump and the White House are getting a second look from traders. According to Altcoin Buzz, these six tokens have a unique political narrative that could set them apart, regardless of short-term market weakness.

The Blue Chips: Ethereum and Solana Lead

Even at the top of the market, the Trump connection is strong.

Why is Ethereum considered a “Trump Coin”?

Ethereum remains the strongest White House-linked asset, largely due to frequent promotion by Trump’s family, particularly Eric Trump. This has fueled speculation that ETH is a core long-term holding for the family, making it a key beneficiary of any pro-crypto government policy. 

At press time, Ethereum trades at $4,404, down 0.86% on the day and over 6% in the past week. Despite short-term weakness, the consistent visibility of ETH in Trump’s orbit makes it a leading beneficiary of potential government-driven crypto adoption.

What’s Solana’s connection?

Alongside Ethereum, Solana has also captured attention. Trump previously used the Solana network to launch political memecoins, and the launch of the Trump-backed USD1 stablecoin on Solana. 

Solana trades at $199, reflecting a weekly decline of just 2.49%, signaling relative strength compared to peers.

Chainlink has emerged as a government partner by integrating official U.S. economic data feeds, a move that underscores its practical utility. Despite this milestone, LINK trades at $22.93, losing more than 11% over the past week. 

Nevertheless, its central role in blockchain infrastructure suggests that long-term opportunities remain strong.

How does XRP and ADA make it to the “Trump Coin” list?

Meanwhile, XRP continues to divide opinion. The token was mentioned by Trump in earlier discussions about a potential U.S. crypto reserve but has yet to see clear adoption. However, the completion of its lawsuit and confirmation of testing by Swift offer renewed optimism. Currently, XRP trades at $2.74, showing an 8.58% decline for the week.

Related: Crypto Market Discount: Ethereum, Cardano and XRP Added to September Altcoin List

Cardano, led by Charles Hoskinson, has gained visibility through direct engagement with Washington policymakers. Its founder has been vocal about shaping crypto regulation, a position that could benefit ADA holders in the long term. Cardano trades at $0.804, down nearly 11% over the week.

The Bottom Line for Traders

Besides these, Cronos (CRO) also secured a spotlight due to a $6.2 billion treasury initiative tied to Trump Media. 

Altcoin Buzz stresses that while short-term volatility persists across these assets, the political connections and institutional discussions surrounding them may offer strategic value for investors anticipating longer cycles.

Related: Raoul Pal Maps Out Altcoin Season: ETH, SOL, XRP Take the Lead

Disclaimer: The information presented in this article is for informational and educational purposes only. The article does not constitute financial advice or advice of any kind. Coin Edition is not responsible for any losses incurred as a result of the utilization of content, products, or services mentioned. Readers are advised to exercise caution before taking any action related to the company.

Source: https://coinedition.com/trump-coins-6-altcoins-driven-by-politics/

Market Opportunity
SIX Logo
SIX Price(SIX)
$0,01209
$0,01209$0,01209
-1,06%
USD
SIX (SIX) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26